Single vs Multiple Inhaler Triple Therapy in the COPD Population

Chest. 2022 Nov;162(5):947-948. doi: 10.1016/j.chest.2022.09.004.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Administration, Inhalation
  • Adrenergic beta-2 Receptor Agonists / therapeutic use
  • Bronchodilator Agents / therapeutic use
  • Drug Combinations
  • Drug Therapy, Combination
  • Humans
  • Muscarinic Antagonists / therapeutic use
  • Nebulizers and Vaporizers*
  • Pulmonary Disease, Chronic Obstructive* / drug therapy

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Bronchodilator Agents
  • Drug Combinations
  • Muscarinic Antagonists